DD261095A5 - Verfahren zur herstellung von antiviralen kombinationen - Google Patents

Verfahren zur herstellung von antiviralen kombinationen Download PDF

Info

Publication number
DD261095A5
DD261095A5 DD87299551A DD29955187A DD261095A5 DD 261095 A5 DD261095 A5 DD 261095A5 DD 87299551 A DD87299551 A DD 87299551A DD 29955187 A DD29955187 A DD 29955187A DD 261095 A5 DD261095 A5 DD 261095A5
Authority
DD
German Democratic Republic
Prior art keywords
antiviral
compound
virus
nucleoside transport
combination
Prior art date
Application number
DD87299551A
Other languages
German (de)
English (en)
Inventor
Thomas P Zimmermann
Gerald Wolberg
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD261095A5 publication Critical patent/DD261095A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DD87299551A 1986-01-30 1987-01-29 Verfahren zur herstellung von antiviralen kombinationen DD261095A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868602346A GB8602346D0 (en) 1986-01-30 1986-01-30 Antiviral combinations

Publications (1)

Publication Number Publication Date
DD261095A5 true DD261095A5 (de) 1988-10-19

Family

ID=10592262

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87299551A DD261095A5 (de) 1986-01-30 1987-01-29 Verfahren zur herstellung von antiviralen kombinationen

Country Status (20)

Country Link
US (1) US4897394A (da)
EP (1) EP0235931B1 (da)
JP (1) JPS62195337A (da)
KR (1) KR870006900A (da)
AT (1) ATE54414T1 (da)
AU (1) AU590817B2 (da)
CA (1) CA1283361C (da)
DD (1) DD261095A5 (da)
DE (1) DE3763597D1 (da)
DK (1) DK46787A (da)
ES (1) ES2031883T3 (da)
FI (1) FI870377L (da)
GB (1) GB8602346D0 (da)
GR (1) GR3000638T3 (da)
HU (1) HU198394B (da)
IL (1) IL81422A0 (da)
MC (1) MC1791A1 (da)
PL (1) PL263871A1 (da)
PT (1) PT84219B (da)
ZA (1) ZA87667B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
EP0684822B1 (en) * 1993-02-19 2002-05-08 Southern Research Institute Carbocyclic deoxyguanosine analogs for the treatment of viral infections
WO1994023723A1 (en) * 1993-04-15 1994-10-27 New York University Adenosine receptor agonists for the promotion of wound healing
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
JPH08510236A (ja) * 1993-05-12 1996-10-29 カール ワイ． ホステトラー 局所使用のためのアシクロビル誘導体
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5677308A (en) * 1996-12-19 1997-10-14 Lerner; A. Martin Method for alleviating spasmodic torticollis
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en) 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
CA2421026C (en) * 2001-10-16 2005-02-15 Avanir Pharmaceuticals Viral inhibition by n-docosanol
US20130172536A1 (en) * 2011-08-16 2013-07-04 Shenzhen Weiguang Biological Products Co.,Ltd. Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
CN105079404A (zh) * 2015-09-07 2015-11-25 夏云强 一种治疗多重耐药菌所致感染性创面的中药外洗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
DE3376326D1 (en) * 1982-10-14 1988-05-26 Wellcome Found Antiviral purine derivatives
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
PT82580B (pt) * 1985-05-15 1989-01-17 Wellcome Found Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
KR870006900A (ko) 1987-08-13
ES2031883T3 (es) 1993-01-01
PT84219B (pt) 1989-07-31
DK46787A (da) 1987-07-31
PL263871A1 (en) 1988-05-12
ATE54414T1 (de) 1990-07-15
US4897394A (en) 1990-01-30
DK46787D0 (da) 1987-01-29
JPS62195337A (ja) 1987-08-28
FI870377A7 (fi) 1987-07-31
FI870377L (fi) 1987-07-31
IL81422A0 (en) 1987-08-31
GR3000638T3 (en) 1991-09-27
HUT42941A (en) 1987-09-28
EP0235931A1 (en) 1987-09-09
HU198394B (en) 1989-10-30
ZA87667B (en) 1988-09-28
AU6813587A (en) 1987-08-06
DE3763597D1 (de) 1990-08-16
MC1791A1 (fr) 1987-10-22
PT84219A (en) 1987-02-01
FI870377A0 (fi) 1987-01-29
EP0235931B1 (en) 1990-07-11
GB8602346D0 (en) 1986-03-05
AU590817B2 (en) 1989-11-16
CA1283361C (en) 1991-04-23

Similar Documents

Publication Publication Date Title
US5405850A (en) Antiviral compositions consisting of acyclovir and a 2-acetyl pyridine derivative
DE3650741T2 (de) Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
DE3687069T2 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
DD264924A5 (de) Verfahren zur herstellung von pyrimidin-nucleosiden
DE3852531T2 (de) Nukleoside und nukleosid-analoge, pharmazeutische zusammensetzung und verfahren für die herstellung der bestandteile.
EP0235931B1 (en) Antiviral combination
DE68906309T2 (de) Methode zur Behandlung von Kachexie und bestimmte dafür anzuwendende Verbindungen.
CH684310A5 (de) Substituierte Adeninderivate.
DD148951A5 (de) Verfahren zur herstellung virozider aminderivate
DE69219482T2 (de) Mit einer einfach ungesättigten omega-9 C18 or C20 Fettsäure O-acylierte Nukleoside
DE4207363A1 (de) Antivirale nucleosidanaloga, ihre herstellung und ihre pharmazeutische verwendung
US5021437A (en) 2-acetylpyridine 5-[(2-chloroanilino)thiocarbonyl]thiocarbonohydrazone compound and salts thereof
EP0374096B1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
DD203464A5 (de) Verfahren zur herstellung einer verbesserten oel-in-wasser-formulierung von 9-(2-hydroxy-aethoxymethyl)-guanin fuer lokale anwendung
DE3873207T2 (de) Antivirale therapie gegen hepatitis b mit 2',3'-didesoxynucleosiden.
DE3228060A1 (de) Verfahren zum behandeln von wuchernden hautkrankheiten
DE3408362C2 (de) Arzneimittel mit antineoplastischer Wirkung
DE3879575T2 (de) Alpha-Carotin zur Wachstumshemmung von Krebszellen.
DE3875324T2 (de) Dl-5-((2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl)thiazolidin-2,4-dion als antiatherosklerosemittel.
DE2818158A1 (de) 5'-amino-5'-deoxythymidin enthaltendes arzneimittel
DE3885090T2 (de) Zusammensetzung und verfahren zur behandlung von hepatitisvirusinfektionen unter verwendung von 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil.
DE60012961T2 (de) Kombinationen von lamivudin und entecavir für behandlung der hepatitis b virus infektion
DD287406A5 (de) Therapeutische nucleoside
DD270656A5 (de) Verfahren zur herstellung eines aeusserlich anwendbaren, antiviralen, in der haut akkumulierenden pharmazeutischen praeparates
DE68905082T2 (de) Virushemmende pharmazeutische zusammensetzung.